Asia
UAE Accepts Alar's Patent Acceptance for Long-Acting Ketamine Injectable Formulations
Alar Pharmaceuticals (TWO:6785) received a notice of acceptance from the UAE Ministry of Economy and Tourism for a patent covering long-acting injectable formulations of ketamine pamoate salts.The company said the patent could facilitate its international licensing business, according to a Friday Taiwan Exchange filing.
TWO:6785
